Skip to Main Content

Paper Details

Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence.
Genome Med
11
2023
B cell, CAF, CAFs, FOS, HCC, JUN, PAX5 module, PD-1, VEGF, advanced hepatocellular carcinoma, cabozantinib, cancer-associated fibroblasts, hepatocellular carcinoma, immune, immune cells, patient, patients, tumor, tumors, tyrosine
Author NameAffiliation
Ludmila DanilovaBloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Ludmila DanilovaConvergence Institute, Johns Hopkins University
Ludmila DanilovaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Ludmila DanilovaBloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Ludmila DanilovaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Ludmila DanilovaConvergence Institute, Johns Hopkins University
Elizabeth M JaffeeBloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Elizabeth M JaffeeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Elizabeth M JaffeeConvergence Institute, Johns Hopkins University
Elana J FertigJohns Hopkins University School of Medicine
Elana J FertigBloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Elana J FertigSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Elana J FertigConvergence Institute, Johns Hopkins University
Elana J FertigJohns Hopkins University School of Medicine
  • 1 - 14

Datasets

Release 1.2